These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 19110447)
41. Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany. Opp J; Tuxhorn I; May T; Kluger G; Wiemer-Kruel A; Kurlemann G; Gross-Selbeck G; Rating D; Brandl U; Bettendorf U; Härtel C; Korn-Merker E Seizure; 2005 Oct; 14(7):476-84. PubMed ID: 16182573 [TBL] [Abstract][Full Text] [Related]
42. Intrapatient variation in antiepileptic drug plasma concentration after generic substitution vs stable brand-name drug regimens. Contin M; Alberghini L; Candela C; Benini G; Riva R Epilepsy Res; 2016 May; 122():79-83. PubMed ID: 26987080 [TBL] [Abstract][Full Text] [Related]
43. Ketter's hypothesis of the mood effects of antiepileptic drugs coupled to the mechanism of action of topiramate and levetiracetam. Roberts GM; Majoie HJ; Leenen LA; Bootsma HP; Kessels AG; Aldenkamp AP; Leonard BE Epilepsy Behav; 2005 May; 6(3):366-72. PubMed ID: 15820345 [TBL] [Abstract][Full Text] [Related]
44. Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy. von Stuelpnagel C; Holthausen H; Kluger G Eur J Paediatr Neurol; 2007 Nov; 11(6):341-5. PubMed ID: 17442601 [TBL] [Abstract][Full Text] [Related]
47. Effect of lamotrigine, levetiracetam & topiramate on neurobehavioural parameters & oxidative stress in comparison with valproate in rats. Sarangi SC; Kakkar AK; Kumar R; Gupta YK Indian J Med Res; 2016 Jul; 144(1):104-111. PubMed ID: 27834333 [TBL] [Abstract][Full Text] [Related]
48. Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy. Kim DW; Lee SY; Shon YM; Kim JH Epilepsia; 2013 Oct; 54(10):e146-9. PubMed ID: 23980720 [TBL] [Abstract][Full Text] [Related]
49. Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population. Wang XQ; Lang SY; Shi XB; Tian HJ; Wang RF; Yang F Seizure; 2010 Nov; 19(9):562-6. PubMed ID: 20888266 [TBL] [Abstract][Full Text] [Related]
50. Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis. Luszczki JJ; Andres MM; Czuczwar P; Cioczek-Czuczwar A; Ratnaraj N; Patsalos PN; Czuczwar SJ Epilepsia; 2006 Jan; 47(1):10-20. PubMed ID: 16417526 [TBL] [Abstract][Full Text] [Related]
51. Evidence for a rapid action of levetiracetam compared to topiramate in refractory partial epilepsy. Specchio LM; Boero G; Specchio N; De Agazio G; De Palo A; de Tommaso M; Beghi E; La Neve A Seizure; 2006 Mar; 15(2):112-6. PubMed ID: 16406697 [TBL] [Abstract][Full Text] [Related]
52. Influence of levetiracetam on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice. Donato Di Paola E; Gareri P; Davoli A; Gratteri S; Scicchitano F; Naccari C; De Sarro G Epilepsy Res; 2007 Jul; 75(2-3):112-21. PubMed ID: 17553669 [TBL] [Abstract][Full Text] [Related]
53. Long term retention of retigabine in a cohort of people with drug resistant epilepsy. Wehner T; Chinnasami S; Novy J; Bell GS; Duncan JS; Sander JW Seizure; 2014 Nov; 23(10):878-81. PubMed ID: 25175006 [TBL] [Abstract][Full Text] [Related]
54. Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication. Kockelmann E; Elger CE; Helmstaedter C Epilepsy Behav; 2004 Oct; 5(5):716-21. PubMed ID: 15380124 [TBL] [Abstract][Full Text] [Related]